In today’s COVID-19 environment, more than ever, the myMatrixx team understands how to innovate and adapt to the changing workforce conditions. Our mission, to provide you with the highest level of customized service, has never been more important. We care deeply about our partners and their injured workers, and we are committed to providing you with the comprehensive information and resources you need to make decisions to support and grow your business.
Please use this resource to stay informed on how myMatrixx is addressing COVID-19 and check in often, as this page is updated frequently.
Image
COVID-19 Helpful Resources
Learn what the Coronavirus is, how it started, symptoms, prevention, and more:
COVID-19 Position Paper
myMatrixx View on COVID-19 Vaccination and Workers' Compensation Coverage
myMatrixx Hosts Virtual Summit on Transportation Safety and COVID-19
December 21, 2020
The transportation industry has played an essential role in the economy since the outbreak of the COVID-19 Pandemic. As a result, workers in this field are facing a number of unique physical and behavioral health challenges that require attention. To foster a productive dialogue on this topic, mymatrixx recently hosted a virtual panel discussion, “Transportation safety and COVID-19,” on Wednesday, December 9th.
Learn more
Second COVID-19 Vaccine Approved Under Emergency Use Authorization
December 21, 2020
The U.S. Food and Drug Administration (FDA) granted an emergency use authorization (EUA) on Dec. 18, 2020, for Moderna’s vaccine to prevent COVID-19.
Learn more
Evernorth’s Dr. Wigneswaran Talks COVID-19 and Herd Immunity
December 21, 2020
There has been a lot of discussion around herd immunity during the course of the pandemic, including some degree of misinformation. In relation to COVID-19, herd immunity refers to the protection that occurs when a sufficient percentage of the population is immune to the disease, whether through natural infection or vaccination.
Learn more
Emergency Use Authorization for the First COVID Vaccine
December 14, 2020
As expected, the U.S. Food and Drug Administration (FDA) followed its independent Vaccines and Related Biological Products Advisory Committee (VRBPAC) recommendation to approve an emergency use authorization (EUA) for the Pfizer/BioNTech COVID-19 vaccine, BNT162b2, on Dec. 11, 2020.
Learn more
New York Extends Formulary Compliance Date for Refill Medications
November 18, 2020
The New York State Workers’ Compensation Board has announced that it will be extending the date for refill compliance with the formulary beyond January 1, 2021. A new date, which is likely to be in spring 2021, will be announced soon.
Learn more
COVID-19 Pandemic Parallels: myMatrixx & Publix Present at WCI Virtual Fall Webinar
November 13, 2020
myMatrixx, presents a new panel on the increasing use of psychotropic drugs among injured workers at WCI Virtual Reboot Seminar.
Learn more
Update to Search for Safe and Effective COVID-19 Vaccines Document
November 09, 2020
One of the top priorities for successfully mitigating COVID-19 is the development of an effective yet safe vaccine. Currently there are more than 100 potential vaccines in development, with projections for commercial availability a year or more away. To provide the latest information, myMatrixx is...
Learn more
Phil Walls Featured in NWCDC CompTalks Series on the Race for a COVID-19 Cure
October 26, 2020
With the annual National Workers’ Compensation and Disability Conference (NWCDC) going virtual this year, the event has expanded into several platforms to engage and educate attendees.
Learn more